These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2745665)
1. Liquid chromatographic and mass spectral analysis of 1-(3,4-methylenedioxyphenyl)-3-butanamines, homologues of 3,4-methylenedioxyamphetamines. Noggle FT; Clark CR; DeRuiter J J Chromatogr Sci; 1989 May; 27(5):240-3. PubMed ID: 2745665 [TBL] [Abstract][Full Text] [Related]
2. Liquid chromatographic and mass spectral analysis of 1-(3,4-methylenedioxyphenyl)-1-propanamines: regioisomers of the 3,4-methylenedioxyamphetamines. DeRuiter J; Clark CR; Noggle FT J Chromatogr Sci; 1990 Mar; 28(3):129-32. PubMed ID: 2273067 [TBL] [Abstract][Full Text] [Related]
3. Liquid chromatographic and mass spectral analysis of N-substituted analogues of 3,4-methylenedioxyamphetamine. Noggle FT; Clark CR; Valaer AK; DeRuiter J J Chromatogr Sci; 1988 Aug; 26(8):410-5. PubMed ID: 3215990 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine. Noggle FT; DeRuiter J; Coker ST; Clark CR J Assoc Off Anal Chem; 1987; 70(6):981-6. PubMed ID: 3436914 [TBL] [Abstract][Full Text] [Related]
5. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA). Noggle FT; Clark CR; Andurkar S; DeRuiter J J Chromatogr Sci; 1991 Mar; 29(3):103-6. PubMed ID: 1676403 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS. Borth S; Hänsel W; Rösner P; Junge T Forensic Sci Int; 2000 Dec; 114(3):139-53. PubMed ID: 11027867 [TBL] [Abstract][Full Text] [Related]
7. Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs. Noggle FT; DeRuiter J; Long MJ J Assoc Off Anal Chem; 1986; 69(4):681-6. PubMed ID: 2875058 [TBL] [Abstract][Full Text] [Related]
8. Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs. Garofano L; Santoro M; Patri P; Guidugli F; Bollani T; Favretto D; Traldi P Rapid Commun Mass Spectrom; 1998; 12(12):779-82. PubMed ID: 9650303 [TBL] [Abstract][Full Text] [Related]
9. Liquid chromatographic properties and aqueous solution stability of N-hydroxy-3,4-methylenedioxyamphetamine. Valaer AK; Ravis WR; Clark CR J Chromatogr Sci; 1990 Sep; 28(9):482-6. PubMed ID: 2273071 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake. Chèze M; Deveaux M; Martin C; Lhermitte M; Pépin G Forensic Sci Int; 2007 Aug; 170(2-3):100-4. PubMed ID: 17629643 [TBL] [Abstract][Full Text] [Related]
11. Potential misrepresentation of 3,4-methylenedioxyamphetamine (MDA). A toxicological warning. Shulgin AT; Jacob P J Anal Toxicol; 1982; 6(2):71-5. PubMed ID: 7098452 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of amphetamine-type compounds for which no reference compound is available: the validation of a theoretical model. Huizer H; Poortman Van Der Meer AJ; Van Egmond HE Sci Justice; 2001; 41(3):185-92. PubMed ID: 11515165 [No Abstract] [Full Text] [Related]
13. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry. Mortier KA; Dams R; Lambert WE; De Letter EA; Van Calenbergh S; De Leenheer AP Rapid Commun Mass Spectrom; 2002; 16(9):865-70. PubMed ID: 11948818 [TBL] [Abstract][Full Text] [Related]
14. Monolithic silica spin column extraction and simultaneous derivatization of amphetamines and 3,4-methylenedioxyamphetamines in human urine for gas chromatographic-mass spectrometric detection. Nakamoto A; Nishida M; Saito T; Kishiyama I; Miyazaki S; Murakami K; Nagao M; Namura A Anal Chim Acta; 2010 Feb; 661(1):42-6. PubMed ID: 20113714 [TBL] [Abstract][Full Text] [Related]
16. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Garrett ER; Seyda K; Marroum P Acta Pharm Nord; 1991; 3(1):9-14. PubMed ID: 1677250 [TBL] [Abstract][Full Text] [Related]
17. 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives. Bost RO J Forensic Sci; 1988 Mar; 33(2):576-87. PubMed ID: 2897421 [TBL] [Abstract][Full Text] [Related]
18. GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB. Thigpen A; DeRuiter J; Clark CR J Chromatogr Sci; 2007; 45(5):229-35. PubMed ID: 17555628 [TBL] [Abstract][Full Text] [Related]
19. GC-MS studies on side chain regioisomers related to substituted methylenedioxyphenethylamines: MDEA, MDMMA, and MBDB. Awad T; Belal T; Maher HM; DeRuiter J; Clark CR J Chromatogr Sci; 2010 Oct; 48(9):726-32. PubMed ID: 20875234 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA). Davis WM; Borne RF Subst Alcohol Actions Misuse; 1984; 5(2):105-10. PubMed ID: 6147902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]